remetinostat (SHP-141) - Medivir
TetraLogic: Q2 2015 Results (TetraLogic) - Aug 7, 2015 - Anticipated data from P2 trial (NCT02213861) in early stage cutaneous T-cell lymphoma at the end of 2015 
Anticipated P2 data • Oncology
http://files.shareholder.com/downloads/AMDA-2C8MW4/524064809x0x843953/5eaeb1b6-a970-44f8-9bda-86a5c74045bb/TLOG_News_2015_8_5_General_Releases.pdf
 
Aug 7, 2015
 
.